Capstone Holding Corp. — Director's Dealing 2010

Dec 21, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Capstone Therapeutics Corp. (CAPS)
CIK: 0000887151
Period of Report: 2010-12-20

Reporting Person: HOLLIMAN JOHN M III (Director, Executive Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-12-20	Common Stock	P	25000	$0.47	Acquired	247614	Direct
2010-12-21	Common Stock	P	25000	$0.45	Acquired	272614	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1658	Indirect
Common Stock	3000	Indirect